Cargando…
The role of FFR in clinical decision making in patients with moderate coronary lesions: a pilot study
Background and Aim: Applying fractional flow reserve (FFR) recently helped to assess borderline coronary defects and also facilitates assessment of these lesions. The present study aimed to assess cost-effectiveness of FFR in detection of these borderline lesions. Methods: This cross-sectional study...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mattioli 1885
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6502121/ https://www.ncbi.nlm.nih.gov/pubmed/30333462 http://dx.doi.org/10.23750/abm.v89i3.5605 |
_version_ | 1783416211233570816 |
---|---|
author | Morteza, Safi Mohammad, Ali Mehrabi Saeed, Alipour Parsa Isa, Khaheshi Mohammadreza, Naderian |
author_facet | Morteza, Safi Mohammad, Ali Mehrabi Saeed, Alipour Parsa Isa, Khaheshi Mohammadreza, Naderian |
author_sort | Morteza, Safi |
collection | PubMed |
description | Background and Aim: Applying fractional flow reserve (FFR) recently helped to assess borderline coronary defects and also facilitates assessment of these lesions. The present study aimed to assess cost-effectiveness of FFR in detection of these borderline lesions. Methods: This cross-sectional study was conducted on140 consecutive patients with 219 diseased arteries who underwent coronary angiography and suffered intermediate coronary lesions. Results: Of 18 patients who candidate for CABG before FFR, only one patient underwent CABG after determining FFR (P-value<0.05), while 15 patients were scheduled for PCI and 2 patients for medical treatment. Of 122 patients who candidate for PCI, 59 were programmed to underwent PCI after FFR determination (P-value<0.05), while the strategy in 63 patients (47 with one-vessel disease, 15 with two vessel diseases, and 1 with three vessel diseases) was modified to medical treatment. Considering strategy modifying from PCI to medical treatment, 101 stents were saved (P-value<0.05). Also, in change of strategy from CABG to PCI, spending has decreased as much as 77.3% (P-value<0.05). Furthermore, the change of treatment approach from PCI on much number of coronary vessels to PCI on less number of coronary lesions led to saving of 52.2% of costs (P-value<0.05). Conclusions:In patients with an intermediate coronary lesion, measuring FFR to guide the decision to determine treatment strategy may lead to significant cost savings. (www.actabiomedica.it) |
format | Online Article Text |
id | pubmed-6502121 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Mattioli 1885 |
record_format | MEDLINE/PubMed |
spelling | pubmed-65021212019-05-08 The role of FFR in clinical decision making in patients with moderate coronary lesions: a pilot study Morteza, Safi Mohammad, Ali Mehrabi Saeed, Alipour Parsa Isa, Khaheshi Mohammadreza, Naderian Acta Biomed Original Article Background and Aim: Applying fractional flow reserve (FFR) recently helped to assess borderline coronary defects and also facilitates assessment of these lesions. The present study aimed to assess cost-effectiveness of FFR in detection of these borderline lesions. Methods: This cross-sectional study was conducted on140 consecutive patients with 219 diseased arteries who underwent coronary angiography and suffered intermediate coronary lesions. Results: Of 18 patients who candidate for CABG before FFR, only one patient underwent CABG after determining FFR (P-value<0.05), while 15 patients were scheduled for PCI and 2 patients for medical treatment. Of 122 patients who candidate for PCI, 59 were programmed to underwent PCI after FFR determination (P-value<0.05), while the strategy in 63 patients (47 with one-vessel disease, 15 with two vessel diseases, and 1 with three vessel diseases) was modified to medical treatment. Considering strategy modifying from PCI to medical treatment, 101 stents were saved (P-value<0.05). Also, in change of strategy from CABG to PCI, spending has decreased as much as 77.3% (P-value<0.05). Furthermore, the change of treatment approach from PCI on much number of coronary vessels to PCI on less number of coronary lesions led to saving of 52.2% of costs (P-value<0.05). Conclusions:In patients with an intermediate coronary lesion, measuring FFR to guide the decision to determine treatment strategy may lead to significant cost savings. (www.actabiomedica.it) Mattioli 1885 2018 /pmc/articles/PMC6502121/ /pubmed/30333462 http://dx.doi.org/10.23750/abm.v89i3.5605 Text en Copyright: © 2018 ACTA BIO MEDICA SOCIETY OF MEDICINE AND NATURAL SCIENCES OF PARMA http://creativecommons.org/licenses/by-nc-sa/4.0 This work is licensed under a Creative Commons Attribution 4.0 International License |
spellingShingle | Original Article Morteza, Safi Mohammad, Ali Mehrabi Saeed, Alipour Parsa Isa, Khaheshi Mohammadreza, Naderian The role of FFR in clinical decision making in patients with moderate coronary lesions: a pilot study |
title | The role of FFR in clinical decision making in patients with moderate coronary lesions: a pilot study |
title_full | The role of FFR in clinical decision making in patients with moderate coronary lesions: a pilot study |
title_fullStr | The role of FFR in clinical decision making in patients with moderate coronary lesions: a pilot study |
title_full_unstemmed | The role of FFR in clinical decision making in patients with moderate coronary lesions: a pilot study |
title_short | The role of FFR in clinical decision making in patients with moderate coronary lesions: a pilot study |
title_sort | role of ffr in clinical decision making in patients with moderate coronary lesions: a pilot study |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6502121/ https://www.ncbi.nlm.nih.gov/pubmed/30333462 http://dx.doi.org/10.23750/abm.v89i3.5605 |
work_keys_str_mv | AT mortezasafi theroleofffrinclinicaldecisionmakinginpatientswithmoderatecoronarylesionsapilotstudy AT mohammadalimehrabi theroleofffrinclinicaldecisionmakinginpatientswithmoderatecoronarylesionsapilotstudy AT saeedalipourparsa theroleofffrinclinicaldecisionmakinginpatientswithmoderatecoronarylesionsapilotstudy AT isakhaheshi theroleofffrinclinicaldecisionmakinginpatientswithmoderatecoronarylesionsapilotstudy AT mohammadrezanaderian theroleofffrinclinicaldecisionmakinginpatientswithmoderatecoronarylesionsapilotstudy AT mortezasafi roleofffrinclinicaldecisionmakinginpatientswithmoderatecoronarylesionsapilotstudy AT mohammadalimehrabi roleofffrinclinicaldecisionmakinginpatientswithmoderatecoronarylesionsapilotstudy AT saeedalipourparsa roleofffrinclinicaldecisionmakinginpatientswithmoderatecoronarylesionsapilotstudy AT isakhaheshi roleofffrinclinicaldecisionmakinginpatientswithmoderatecoronarylesionsapilotstudy AT mohammadrezanaderian roleofffrinclinicaldecisionmakinginpatientswithmoderatecoronarylesionsapilotstudy |